Tuberculosis Drug Resistance: A Global Threat | Zendy

Jean B. Nachega | Zendy; Richard E. Chaisson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tuberculosis Drug Resistance: A Global Threat

Author(s) -

Jean B. Nachega,

Richard E. Chaisson

Publication year - 2003

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/344657

Subject(s) - medicine , tuberculosis , drug resistance , multiple drug resistance , outbreak , drug , extensively drug resistant tuberculosis , intensive care medicine , virology , mycobacterium tuberculosis , pharmacology , microbiology and biotechnology , biology , pathology

Resistance to antituberculosis drugs has been a problem since the era of chemotherapy began. After dramatic outbreaks of multidrug-resistant tuberculosis (MDR-TB) in the early 1990s, resistance became recognized as a global problem. MDR-TB now threatens the inhabitants of countries in Europe, Asia, Africa, and the Americas. An understanding of the molecular basis of drug resistance may contribute to the development of new drugs. Management of MDR-TB relies on prompt recognition and treatment with at least 3 drugs to which an isolate is susceptible.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research